# Quality of Life and Neurodevelopment Assessment of Children With Congenital Heart Disease Aged 2 to 4 Years

> **NCT04812210** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 248 (actual)

## Conditions studied

- Congenital Heart Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04812210
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-30
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2022-04-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04812210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04812210, "Quality of Life and Neurodevelopment Assessment of Children With Congenital Heart Disease Aged 2 to 4 Years". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04812210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*